Adhesion of tumoricidal eosinophils to MCA-38 colon adenocarcinoma cells involves protein tyrosine kinase activation and is diminished by elevated cyclic AMP in the effector cell

International Journal of Oncology

Volumn 13, Issue 6, 1998, Pages 1305-1311

  Taylor, Rebecca ^a   Lee, Timothy D G ^a   Hoskin, David W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adhesion; Colon adenocarcinoma; Cytotoxicity; Eosinophils; Signal transduction

Indexed keywords

8 BROMO CYCLIC AMP; CALPHOSTIN C; CD11B ANTIGEN; CYCLIC AMP; INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; WORTMANNIN;

ADENOCARCINOMA; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ADHESION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EFFECTOR CELL; EOSINOPHIL; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031773327     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.6.1305     Document Type: Article

References (34)

1. Wardlaw AJ, Moqbel R and Kay AB: Eosinophils: biology and role in disease. Adv Immunol 60: 151-266, 1995.
2. Tepper RI, Coffman, RL and Leder P: An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257: 548-551, 1992.
3. Goldsmith MM, Belchis DA, Cresson DH, Merritt, WD III and Askin FB: The importance of the eosinophil in head and neck cancer. Otolaryngol Head Neck Surg 106: 27-33, 1992.
4. Pretlow TP, Keith EF, Cryar AK, Bartolucci AA, Pitts AM, Pretlow TG II, Kimball PM and Boohaker EA: Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. Cancer Res 43: 2997-3000, 1983.
5. Samoszuk MK, Nguyen V, Gluzman I and Pham PH: Occult deposition of eosinophil peroxidase in a subset of human breast carcinomas. Am J Pathol 148: 701-706, 1996.
6. Bethwaite PB, Holloway LJ, Yeong ML and Thornton A: Effect of tumour associated tissue eosinophilia on survival of women with carcinoma of the uterine cervix. J Clin Pathol 46: 1016-1020, 1993.
7. Ishimitsu T and Torisu M: The role of eosinophils in interleukin-2/lymphokine-activated killer cell therapy. Surgery 113: 192-199, 1993.
8. Rivoltini L, Viggiano V, Spinazzè S, Santoro A, Colombo MP, Takatsu K and Parmiani G: In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5. Int J Cancer 54: 8-15, 1993.
9. Taylor R, Lee TDG and Hoskin DW: Assessment of eosinophil accumulation in the peritoneal cavity of Balb/c mice infected with Mesocestoides corti or Nippostrongylus brasiliensis larvae or sensitized with ovalbumin. J Immunol Methods 212: 105-108, 1998.
10. Gallinger S, Hoskin DW, Mullen JBM, Wong AHC and Roder JC: Comparison of cellular immunotherapies and anti-CD3 in the treatment of MCA-38-LD experimental hepatic metastases in C57BL/6 mice. Cancer Res 50: 2476-2480, 1990.
11. Weller PF: The immunobiology of eosinophils. N Engl J Med 324: 1110-1118, 1991.
12. Delpozo V, Deandres B, Martin E, Maruri N, Zubeldia JM, Palomino P and Lahoz C: Murine eosinophils and IL-1: αIL-1 mRNA detection by in situ hybridization. J Immunol 144: 3117-3122, 1990.
13. Stewart BH and Hoskin DW: Inhibition of protein tyrosine kinases or protein kinase C prevents nonspecific killer T lymphocyte-mediated tumoricidal activity. Biochim Biophys Acta 1356: 333-342, 1997.
14. Springer TA: Adhesion receptors of the immune system. Nature 346: 425-433, 1990.
15. Hartnell A, Moqbel R, Walsh GM, Bradley B and Kay AB: Fcγ and CD11/CD18 receptor expression on normal density and low density human eosinophils. Immunology 69: 264-270, 1990.
16. 1, (very late antigen-4) dependent. J Immunol 146: 3419-3423, 1991.
17. 7 on human leukocytes. J Immunol 153: 517-528, 1994.
18. Kobayashi E, Nakano H, Morimoto M and Tamaoki T: Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitory of protein kinase C. Biochem Biophys Res Commun 159: 548-553, 1989.
19. Umezawa K and Imoto M: Use of erbstatin as protein tyrosine kinase inhibitors. Methods Enzymol 201: 379-385, 1991.
20. Arcaro A and Wymann MP: Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: The role of phosphatidyl-inositol 3,4,5-triphosphate in neutrophil responses. Biochem J 296: 297-301, 1993.
21. Kogan JH, Nestler EJ and Aghajanian GK: Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur J Pharmacol 211: 47-53, 1992.
22. Hoskin DW, Williams BA, Fitzpatrick L and Makrigiannis AP: Cell biology and possible therapeutic applications of anti-CD3-activated killer-T cells. Int J Mol Med 1: 893-902, 1998.
23. Lowin B, Hahne M, Mattmann C and Tschopp J: Cytolytic T-cell cytotoxicity is mediated through perforin and fas lytic pathways. Nature 370: 650-652, 1994.
24. Mori S, Jewett A, Murakami-Mori K, Cavalcanti M and Bonavida B: The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent. Cancer Immunol Immunother 44: 282-290, 1997.
25. 7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin. Immunology 89: 112-119, 1996.
26. 1 integrin/fibronectin interaction in vitro by the serine/threonine phosphatase calcineurin. Biochemistry 34: 5104-5112, 1995.
27. Yamada KM: Adhesive recognition sequences. J Biol Chem 266: 12809-12812, 1991.
28. Pardi R, Inverardi L, Rugarli C and Bender JR: Antigenreceptor complex stimulation triggers protein kinase C-dependent Cd1 1a/CD18-cytoskeleton association in T lymphocytes. J Cell Biol 116: 1211-1220, 1992.
29. + T cell adhesion to B cells. Cell Immunol 150: 439-446, 1993.
30. Shimizu Y, Mobley JL, Finkelstein LD and Chan ASH: A role for phosphatidylinositol 3-kinase in the regulation of 1 integrin activity by the CD2 antigen. J Cell Biol 131: 1867-1880, 1996.
31. McGregor PE, Agrawal DK and Edwards JD: Attenuation of human leukocyte adherence to endothelial cell monolayers by tyrosine kinase inhibitors. Biochem Biophys Res Commun 198: 359-365, 1994.
32. Clark EA and Brugge JS: Integrins and signal transduction pathways: The road Taken. Science 268: 233-239, 1995.
33. Young MRI: Eicosanoids and the immunology of cancer. Cancer Metastasis Rev 13: 337-348, 1994.
34. 2 leukocyte integrin (LFA-1) by cyclic AMP-dependent protein kinase. J Immunol 156: 2273-2279, 1996.